A SURVEY OF DRUG-RELATED-PROBLEMS AMONG PATIENTS TREATED FOR ALLERGY SYMPTOMS IN COMMUNITY PHARMACIES AT NEGERI SEMBILAN, MALAYSIA
Objectives: Patients treated for allergy symptoms are at risk of acquiring drug-related problems (DRPs), as they require various types and forms of medications. Inappropriate therapeutic management of allergy symptoms could lead to the complication of diseases such as asthma and diabetes. To date, DRPs among patients treated for allergy symptoms have not been well established in Malaysia especially in community pharmacies setting. The main objective of this study is to identify factors and medications associated with DRPs among patients treated for allergy symptoms in community pharmacies.
Methods: This descriptive and cross-sectional study was conducted in community pharmacies in Negeri Sembilan, Malaysia from June 2011 to April 2012. The Pharmaceutical Care Network Europe Classification Version (PCNE) 6.2 was used as a tool to classify DRPs.
Results: A total of 378 patients were recruited according to inclusion and exclusion criteria. A total of 792DRPs were found; an average of 1.97 (SD = 1.6) DRP per patient. Significant DRP association (p<0.05) was detected from the usage of corticosteroids and antihistamines. Meanwhile, poly pharmacy and forgetfulness were factors significantly associated (p<0.05) as causes of DRPs.
Conclusion: There is a high occurrence of DRPs among patients who are treated for allergy symptoms. Identifying types and causes of DRPs in a community pharmacy would facilitate medication safety awareness among healthcare providers and patients.
2. WAO White Book on Allergy.[Internet] 2011 [Cited 2012 Sep 9] Available from:http:// www.worldallergy.org/ publications/ wao_white_book.pdf
3. Majkowska-Wojciechowska B, PeÅ‚ka J, Korzon L, KozÅ‚owska A, KaczaÅ‚a M, Jarzebska M, et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. J Allergy 2007;62(9):1044.
4. American Academy of Allergy, Asthma & Immunology (AAAAI). [Internet] 2011 [Cited 2012 Sep 9] Available from:http:// www.aaaai.org/about-the-aaaai/newsroom/allergy-statistics. aspx
5. Laitinen T, Daly MJ, Rioux JD, Kauppi P, Laprise C, PetÃ¤ys T, et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. J Nat Genet 2001;28:87 â€“ 91.
6. Malaysian Society of Allergy and immunology. [Internet] 2010 [Cited 2011 Sep 9]. Available from: http:// www. allergymsai. org/article.php?aid=99
7. Knowles SR, Uetrecht J, Shear NH. Adverse Drug Reactions, Idiosyncratic drug reactions:the reactive metabolite syndromes. J Lancet 2000;356 (9241):1587â€“91.
8. Asthma and Allergy Centre. [Internet] Date Unknown[Cited 2012 Feb 8] Available from: http:// www. aacenter. com/ page/ drugs--supplements.
9. Pharmaceutical Care Network Europe Foundation 2010. Classification for drug-related problems. [Internet] 2010 [Cited 2011 Feb 10] Available from:http:// www. pcne. org/ sig/drp/documents/drp/PCNE%20classification%20V6-2.pdf
10. Hayes BD, Klein-Schwartz W, Barrueto F Jr. Polypharmacy and the Geriatric Patient:Emergencies in the Elderly Patient. J Clinics in Geriatric Medicine 2007;23 (2):371-90.
11. American Academy of Allergy, Asthma & Immunology (AAAAI). [Internet] 2011. [Cited 2012 Sep 9] Available from: http:// www.aaaai.org/about-the-aaaai/newsroom/allergy-statistics. aspx
12. Rupp MT, De Young M, Schondelmeyer SW. Prescribing Problems and Pharmacist Interventions in Community Practice. J Medical Care 1992;30 (10):926-40.
13. PCNE Classification for Drug Related Problems V 6.2
14. [Internet] 2010 [Cited 2011 Jan 12] Available from:http:// www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf
15. Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H;ESCP-SIR Rejkjavik Community Pharmacy Research Group. Drug related problems identified by European community pharmacists in patients discharged from hospital. J Pharm World Sci 2004 Dec;26(6):353-60.
16. American Academy of Allergy, Asthma & Immunology (AAAAI). [Internet] 2011 [Cited 2012 Sep 9] Available from:
18. Kaur B, Anderson HR, Austin J, Burr M, Harkins LS, Strachan DP, et al. Prevalence of asthma symptoms, diagnosis, and treatment in 12â€“14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). BMJ 1998;316:118.
19. Fireman P. Therapeutic approaches to allergic rhinitis: Treating the child. J of Allergy and Clinical Immunology 2000; 105(6)2:S616â€“S21.
20. Carsten F, Hywel CW. Evidence based management of atopic eczema. J Arch Dis Child Educ Pract Ed [Internet]. 2004 [cited 2012 Jan 6] 89(2):35-39. doi:10.1136/ adc.2004. 050237. Available from:http://ep.bmj.com/content/89/2/ep35.full.
21. Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, et al. Mechanisms of Action of Topical Corticosteroids in Psoriasis. Int J Endocrinol 2012;2012:561018.
22. Hindmarch I, Shamsi Z. Antihistamines:models to assess sedative properties, assessment of sedation, safety and other side-effects. J Clin Exp Allergy 1999;29 (Suppl 3):133-42.
23. Gupta P, O' Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people:recommendations for prescribing. J Drugs Aging 2008;25(5):415-43.
24. Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, et al. Mechanisms of Action of Topical Corticosteroids in Psoriasis. Int J Endocrinol 2012;2012:561018.
25. American Academy of Allergy, Asthma & Immunology (AAAAI). [Internet] 2011 [Cited 2012 Sep 9] Available from:http:// www.aaaai.org/conditions-and-treatments/ library/ at-a glance/reactions. As px medications-and-drug-allergic-
26. Knowles SR, Uetrecht J, Shear NH. Adverse Drug Reactions, Idiosyncratic drug reactions:the reactive metabolite syndromes. J Lancet 2000;356 (9241):1587-91.
27. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. British J of Clinical Pharmacology 2007;63(2):187-95.
28. Mirkov S. Implementation of a pharmacist medication review clinic for haemodialysis patients. NZ Medical J 2009;122(1297):25.